Top

Published in:

11-09-2023 | Diabetes | Original Paper

Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel’s Mental Health Reform

Authors: Deborah Barasche-Berdah, Eliana Ein-Mor, Ronit Calderon-Margalit, Adam J Rose, Michal Krieger, Shuli Brammli-Greenberg, Arye Ben-Yehuda, Orly Manor, Arnon D. Cohen, Edna Bar-Ratson, Ronen Bareket, Eran Matz, Ora Paltiel

Published in: Community Mental Health Journal | Issue 2/2024

Abstract

Diabetes Mellitus (DM) is more common among individuals with severe mental illness (SMI). We aimed to assess quality-of-care-indicators in individuals with SMI following the 2015 Israel’s Mental-Health-reform. We analyzed yearly changes in 2015–2019 of quality-of-care-measures and intermediate-DM-outcomes, with adjustment for gender, age-group, and socioeconomic status (SES) and compared individuals with SMI to the general adult population. Adults with SMI had higher prevalences of DM (odds ratio (OR) = 1.64; 95% confidence intervals (CI): 1.61–1.67) and obesity (OR = 2.11; 95% CI: 2.08–2.13), compared to the general population. DM prevalence, DM control, and obesity rates increased over the years in this population. In 2019, HbA1c testing was marginally lower (OR = 0.88; 95% CI: 0.83–0.94) and uncontrolled DM (HbA1c > 9%) slightly more common among patients with SMI (OR = 1.22; 95% CI: 1.14–1.30), control worsened by decreasing SES. After adjustment, uncontrolled DM (adj. OR = 1.02; 95% CI: 0.96–1.09) was not associated with SMI. Cardio-metabolic morbidity among patients with SMI may be related to high prevalences of obesity and DM rather than poor DM control. Effective screening for metabolic diseases in this population and social reforms are required.

Available only for authorised users

Afzal, M., Siddiqi, N., Ahmad, B., Afsheen, N., Aslam, F., Ali, A., et al. (2021). Prevalence of overweight and obesity in people with severe mental illness: Systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2021.769309CrossRefPubMedPubMedCentral

Aviram, U., & Azary-Viesel, S. (2018). Mental health reform in Israel: Challenge and opportunity part ii: implementation of the reform—issues and problems. Israel Journal of Psychiatry, 55(3), 55–64.

Barnett, A. H., Mackin, P., Chaudhry, I., Farooqi, A., Gadsby, R., Heald, A., et al. (2007). Minimising metabolic and cardiovascular risk in schizophrenia: Diabetes, obesity and dyslipidaemia. Journal of Psychopharmacology, 21(4), 357–373. https://doi.org/10.1177/0269881107075509CrossRefPubMed

Blanchard, E., & Samaras, K. (2014). Double jeopardy: Diabetes and severe mental illness. addressing the special needs of this vulnerable group. Diabetes Management, 4(4), 339–353. https://doi.org/10.2217/dmt.14.24CrossRef

Brink, M., Green, A., Bojesen, A. B., Lamberti, J. S., Conwell, Y., & Andersen, K. (2019). Excess medical comorbidity and mortality across the lifespan in schizophrenia.: A nationwide danish register study. Schizophrenia Research, 206, 347–354. https://doi.org/10.1016/j.schres.2018.10.020.CrossRefPubMed

Brown, C., Geiszler, L. C., Lewis, K. J., & Arbesman, M. (2018). Effectiveness of interventions for weight loss for people with serious mental illness: A systematic review and meta-analysis. American Journal of Occupational Therapy. https://doi.org/10.5014/ajot.2018.033415CrossRef

Bushe, C., & Holt, R. (2004). Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. British Journal of Psychiatry, 184(SUPPL. 47), S67–S71. https://doi.org/10.1192/bjp.184.47.s67.CrossRef

Butterworth, P. (2003). The prevalence of mental disorders among income support recipients: An important issue for welfare reform. Australian and New Zealand Journal of Public Health, 27(4), 441–448. https://doi.org/10.1111/j.1467-842X.2003.tb00424.x.CrossRefPubMed

Castillo-Sánchez, M., Fàbregas-Escurriola, M., Bergè-Baquero, D., Fernández-SanMartín, M., & Goday-Arno, A. (2017). Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: Are we equally exhaustive as with the general population? Clinical and Experimental Hypertension, 39(5), 441–447. https://doi.org/10.1080/10641963.2016.1267200.CrossRefPubMed

Central Bureau of Statistics. Socio-economic index. (2022). https://www.cbs.gov.il/en/subjects/Pages/Socio-Economic-Index-of-Local-Authorities.aspx. Accessed 22 September 2022.

Chesney, E., Goodwin, G. M., & Fazel, S. (2014). Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry, 13(2), 153–160. https://doi.org/10.1002/wps.20128.CrossRefPubMedPubMedCentral

Clarfield, A. M., Manor, O., Nun, G., Bin, Shvarts, S., Azzam, Z. S., Afek, A., et al. (2017). Health and health care in Israel: An introduction. The Lancet, 389(10088), 2503–2513. https://doi.org/10.1016/S0140-6736(17)30636-0.CrossRef

Cohen, A., Ashworth, M., Askey, A., & Ismail, K. (2018). Diabetes outcomes in people with severe mental illness. British Journal of General Practice, 68(669), 166–167. https://doi.org/10.3399/bjgp18X695381.CrossRef

De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H. J. (2009). Cardiovascular disease and diabetes in people with severe mental illness position statement from the european Psychiatric Association (EPA), supported by the European Association for the study of diabetes (EASD) and the European Society of Cardiology (ESC. European Psychiatry, 24(6), 412–424. https://doi.org/10.1016/j.eurpsy.2009.01.005.CrossRefPubMed

Desai, M. M., Rosenheck, R. A., Druss, B. G., & Perlin, J. B. (2002). Mental disorders and quality of diabetes care in the veterans health administration. American Journal of Psychiatry, 159(9), 1584–1590. https://doi.org/10.1176/appi.ajp.159.9.1584.CrossRefPubMed

Dickerson, F., Origoni, A., Schroeder, J., Schweinfurth, L. A. B., Stallings, C., Savage, C. L. G., et al. (2016). Mortality in schizophrenia and bipolar disorder: Clinical and serological predictors. Schizophrenia Research, 170(1), 177–183. https://doi.org/10.1016/j.schres.2015.11.010.CrossRefPubMed

Dinan, T., Holt, R., Kohen, D., Thakore, J., Haddad, P., Baker, R., et al. (2004). Schizophrenia and diabetes 2003” expert consensus meeting, Dublin, 3–4 october 2003: Consensus summary. British Journal of Psychiatry. https://doi.org/10.1192/bjp.184.47.s112CrossRef

Dixon, L. B., Kreyenbuhl, J. A., Dickerson, F. B., Donner, T. W., Brown, C. H., Wolheiter, K., et al. (2004). A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses. Psychiatric Services, 55(8), 892–900. https://doi.org/10.1176/appi.ps.55.8.892.CrossRefPubMed

Eckel, R. H., Alberti, K. G. M. M., Grundy, S. M., & Zimmet, P. Z. (2010). The metabolic syndrome. The Lancet. https://doi.org/10.1016/S0140-6736(09)61794-3.CrossRef

Fernández Guijarro, S., Miguel García, C., Pomarol-Clotet, E., Egea López, E. N., Martí, B., M. D., & Rigol Cuadra, M. A. (2020). Metabolic syndrome screening in people with severe Mental illness: Results from two Spanish Community Mental Health Centers. Journal of the American Psychiatric Nurses Association, 26(2), 162–171. https://doi.org/10.1177/1078390319826686.CrossRefPubMed

Frayne, S. M., Halanych, J. H., Miller, D. R., Wang, F., Lin, H., Pogach, L., et al. (2005). Disparities in diabetes care: Impact of mental illness. Archives of Internal Medicine, 165(22), 2631–2638. https://doi.org/10.1001/archinte.165.22.2631.CrossRefPubMed

Gal, G., Levav, I., & Kodesh, A. (2022). Impact of the mental health reform in Israel on health care and mortality among people with severe mental illness. Research Square preprint. https://doi.org/10.21203/rs.3.rs-2230826/v1.CrossRef

Goldberg, R. W., Kreyenbuhl, J. A., Medoff, D. R., Dickerson, F. B., Wohlheiter, K., Fang, L. J., et al. (2007). Quality of diabetes care among adults with serious mental illness. Psychiatric Services, 58(4), 536–543. https://doi.org/10.1176/ps.2007.58.4.536.CrossRefPubMed

Han, L., Doran, T., Holt, R. I. G., Hewitt, C., Jacobs, R., Prady, S. L., et al. (2021). Impact of severe mental illness on healthcare use and health outcomes for people with type 2 diabetes: A longitudinal observational study in England. British Journal of General Practice, 71(709), E565–E573. https://doi.org/10.3399/BJGP.2020.0884.CrossRef

Holt, R. I. G., & Peveler, R. C. (2006). Association between antipsychotic drugs and diabetes. Diabetes Obesity and Metabolism, 8(2), 125–135. https://doi.org/10.1111/j.1463-1326.2005.00495.x.CrossRef

Holt, R. I. G., & Peveler, R. C. (2011). Metabolic syndrome and Mental Illness. The Metabolic Syndrome: Second Edition, 177–193. https://doi.org/10.1002/9781444347319.ch11.

Israel Health Indicators (2022). Israel National Program for Quality Indicators in Community Healthcare website. https://en.israelhealthindicators.org/. Accessed 22 September 2022.

Jafari, S., Fernandez-Enright, F., & Huang, X. F. (2012). Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects. Journal of Neurochemistry, 120(3), 371–384. https://doi.org/10.1111/j.1471-4159.2011.07590.x.CrossRefPubMed

Jaffe, D. H., Shmueli, A., Ben-Yehuda, A., Paltiel, O., Calderon, R., Cohen, A. D., et al. (2012). Community healthcare in Israel: Quality indicators 2007–2009. Israel Journal of Health Policy Research, 1(1), 3. https://doi.org/10.1186/2045-4015-1-3.CrossRefPubMedPubMedCentral

Jones, S., Howard, L., & Thornicroft, G. (2008). Diagnostic overshadowing”: Worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.2008.01211.x.CrossRefPubMed

Jørgensen, M., Mainz, J., Carinci, F., Thomsen, R. W., & Johnsen, S. P. (2018). Quality and predictors of diabetes care among patients with schizophrenia: A danish nationwide study. Psychiatric Services, 69(2), 179–185. https://doi.org/10.1176/appi.ps.201600460.CrossRefPubMed

Kodesh, A., Goldshtein, I., Gelkopf, M., Goren, I., Chodick, G., & Shalev, V. (2012). Epidemiology and comorbidity of severe mental illnesses in the community: Findings from a computerized mental health registry in a large israeli health organization. Social Psychiatry and Psychiatric Epidemiology, 47(11), 1775–1782. https://doi.org/10.1007/s00127-012-0478-9.CrossRefPubMed

Kovess, V., Gysens, S., Poinsard, R., Chanoit, P. F., & Labarte, S. (1999). Mental health and use of care in people receiving a french social benefit. Social Psychiatry and Psychiatric Epidemiology, 34(11), 588–594. https://doi.org/10.1007/s001270050179.CrossRefPubMed

Krein, S. L., Bingham, C. R., McCarthy, J. F., Mitchinson, A., Payes, J., & Valenstein, M. (2006). Diabetes treatment among VA patients with comorbid serious mental illness. Psychiatric Services, 57(7), 1016–1021. https://doi.org/10.1176/ps.2006.57.7.1016.CrossRefPubMed

Lindenmayer, J. P., Nathan, A. M., & Smith, R. C. (2001). Hyperglycemia associated with the use of atypical antipsychotics. Journal of Clinical Psychiatry, 62(SUPPL), 30–38.PubMed

Lund, C., Breen, A., Flisher, A. J., Kakuma, R., Corrigall, J., Joska, J. A., et al. (2010). Poverty and common mental disorders in low and middle income countries: A systematic review. Social Science and Medicine, 71(3), 517–528. https://doi.org/10.1016/j.socscimed.2010.04.027.CrossRefPubMed

Lurie, I., Shoval, G., Hoshen, M., Balicer, R., Weiser, M., Weizman, A., & Krivoy, A. (2021). The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study. Schizophrenia Research. https://doi.org/10.1016/j.schres.2021.08.019.CrossRefPubMed

Mangurian, C., Schillinger, D., Newcomer, J. W., Vittinghoff, E., Essock, S., Zhu, Z., et al. (2020). Comorbid diabetes and severe Mental illness: Outcomes in an Integrated Health Care Delivery System. Journal of General Internal Medicine, 35(1), 160–166. https://doi.org/10.1007/s11606-019-05489-3.CrossRefPubMed

Martin, J. L., McLean, G., Park, J., Martin, D. J., Connolly, M., Mercer, S. W., & Smith, D. J. (2014). Impact of socioeconomic deprivation on rate and cause of death in severe mental illness. Bmc Psychiatry. https://doi.org/10.1186/s12888-014-0261-4CrossRefPubMedPubMedCentral

McGinty, E. E., Baller, J., Azrin, S. T., Juliano-Bult, D., & Daumit, G. L. (2015). Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophrenia Research, 165(2–3), 227–235. https://doi.org/10.1016/j.schres.2015.04.010.CrossRefPubMed

McIntyre, R. S., Konarski, J. Z., Misener, V. L., & Kennedy, S. H. (2005). Bipolar disorder and diabetes mellitus: Epidemiology, etiology, and treatment implications. Annals of Clinical Psychiatry, 17(2), 83–93. https://doi.org/10.1080/10401230590932380.CrossRefPubMed

Melkersson, K., & Dahl, M. L. (2004). Adverse metabolic effects associated with atypical antipsychotics: Literature review and clinical implications. Drugs, 64(7), 701–723. https://doi.org/10.2165/00003495-200464070-00003.CrossRefPubMed

Ministry of health (2019). Mental Health in Israel- Statistical abstract. https://www.health.gov.il/PublicationsFiles/mtl-yearbook-2019.pdf. Accessed 22 September 2022.

Ministry of Health (2015). Mental Health Reform- Israeli Ministry of Health. https://www.health.gov.il/English/Topics/Mental_Health/Pages/default.aspx. Accessed 22 September 2022.

Mir, S., & Taylor, D. (2001). Atypical antipsychotics and hyperglycaemia. International Clinical Psychopharmacology, 16(2), 63–74. https://doi.org/10.1097/00004850-200103000-00001.CrossRefPubMed

Mitchell, A. J., Malone, D., & Doebbeling, C. C. (2009). Quality of medical care for people with and without comorbid mental illness and substance misuse: Systematic review of comparative studies. British Journal of Psychiatry, 194(6), 491–499. https://doi.org/10.1192/bjp.bp.107.045732.CrossRef

Mulligan, K., McBain, H., Lamontagne-Godwin, F., Chapman, J., Haddad, M., Jones, J., et al. (2017). Barriers and enablers of type 2 diabetes self-management in people with severe mental illness. Health Expectations, 20(5), 1020–1030. https://doi.org/10.1111/hex.12543.CrossRefPubMedPubMedCentral

Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., & Lieberman, J. A. (2006). Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline. Schizophrenia Research, 86(1–3), 15–22. https://doi.org/10.1016/j.schres.2006.06.026.CrossRefPubMed

National Diabetes Audit (2020). National Diabetes Audit- Care Processes and Treatment Targets 2019–2020, Interactive report. https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/care-processes-and-treatment-targets-3rd-quarter-january-december-2020-data-release. Accessed 22 September 2022.

National Quality Use of Medicines, & Indicators, A. H. (2014). Percentage of patients taking antipsychotic medicines who receive appropriate monitoring for the development of metabolic side effects- Australian Commission on Safety and Quality in Health Care. https://www.safetyandquality.gov.au/sites/default/files/migrated/SAQ127_Indicators_7.4.docx. Accessed 22 September 2022.

Ng-Mak, D., & Rajagopalan, K. (2019). Examining quality of care for individuals treated for mental health using the HEDIS mental health quality measures. Current Medical Research and Opinion, 35(1), 87–95. https://doi.org/10.1080/03007995.2018.1532883.CrossRefPubMed

NHS (2021). Quality and Outcomes Framework (QOF) - NHS Digital. The NHS Outcomes Framework. https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/general-practice-data-hub/quality-outcomes-framework-qof. Accessed 22 September 2022.

NICE (2014). National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. https://www.nice.org.uk/guidance/cg178. Accessed 22 September 2022.

NICE (2022). NICE recommended care processes. http://www.nice.org.uk/guidance/conditions-and-diseases/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions/diabetes. Accessed 22 September 2022.

O’Neill, S., & O’Driscoll, L. (2015). Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obesity Reviews, 16(1), 1–12. https://doi.org/10.1111/obr.12229.CrossRefPubMed

Points Location Intelligence (September 2022). (n.d.). https://points.co.il/. Accessed 22.

Rathmann, W., Pscherer, S., Konrad, M., & Kostev, K. (2016). Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses. Primary Care Diabetes, 10(1), 36–40. https://doi.org/10.1016/j.pcd.2015.04.001.CrossRefPubMed

Regenold, W. T., Thapar, R. K., Marano, C., Gavirneni, S., & Kondapavuluru, P. V. (2002). Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. Journal of Affective Disorders, 70(1), 19–26. https://doi.org/10.1016/S0165-0327(01)00456-6.CrossRefPubMed

Reiss, F. (2013). Socioeconomic inequalities and mental health problems in children and adolescents: A systematic review. Social Science and Medicine. https://doi.org/10.1016/j.socscimed.2013.04.026.CrossRefPubMed

Russell, J. M., & Mackell, J. A. (2001). Bodyweight gain associated with atypical antipsychotics: Epidemiology and therapeutic implications. Cns Drugs, 15(7), 537–551. https://doi.org/10.2165/00023210-200115070-00004.CrossRefPubMed

Schmidt, E. M., Barnes, J., Chen, C., Trafton, J., Frayne, S., & Harris, A. H. S. (2019). Patient and Health Care factors Associated with Long-term Diabetes Complications among adults with and without Mental Health and Substance Use Disorders. JAMA Network Open, 2(9), e1912060. https://doi.org/10.1001/jamanetworkopen.2019.12060.CrossRefPubMedPubMedCentral

Scott, D., & Happell, B. (2011). The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues in Mental Health Nursing, 32(9), 589–597. https://doi.org/10.3109/01612840.2011.569846.CrossRefPubMed

Smith, R., Han, L., Ali, S., Prady, S. L., Taylor, J., Hughes, T., et al. (2019). Glucose, cholesterol and blood pressure in type II diabetes: A longitudinal observational study comparing patients with and without severe mental illness. Journal of Psychiatric and Mental Health Nursing, 26, 347–357. https://doi.org/10.1111/jpm.12546.CrossRefPubMed

Toalson, P., Ahmed, S., Hardy, T., & Kabinoff, G. (2004). The metabolic syndrome in patients with severe Mental Illnesses. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v06n0402CrossRef

VA, H. (2020). Health Disparities in Quality Indicators of Healthcare Among Adults with Mental Illness. https://www.hsrd.research.va.gov/publications/esp/health_disparitiesMH-REPORT.pdf. Accessed 22 September 2022.

Van Winkel, R., De Hert, M., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2006). Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: Evaluation of incidence and screening methods. Journal of Clinical Psychiatry, 67(10), 1493–1500. https://doi.org/10.4088/JCP.v67n1002.CrossRefPubMed

Van Winkel, R., De Hert, M., Van Eyck, D., Hanssens, L., Wampers, M., Scheen, A., & Peuskens, J. (2008). Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disorders, 10(2), 342–348. https://doi.org/10.1111/j.1399-5618.2007.00520.x.CrossRefPubMed

Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., et al. (2016). Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: A systematic review and large scale meta-analysis. World Psychiatry, 15(2), 166–174. https://doi.org/10.1002/wps.20309.CrossRefPubMedPubMedCentral

Vedal, T. S. J., Steen, N. E., Birkeland, K. I., Dieset, I., Reponen, E. J., Laskemoen, J. F., et al. (2019). Adipokine levels are associated with insulin resistance in antipsychotics users independently of BMI. Psychoneuroendocrinology, 103, 87–95. https://doi.org/10.1016/j.psyneuen.2019.01.001.CrossRefPubMed

Verhaeghe, N., De Maeseneer, J., Maes, L., Van Heeringen, C., & Annemans, L. (2011). Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: A systematic review. International Journal of Behavioral Nutrition and Physical Activity. https://doi.org/10.1186/1479-5868-8-28CrossRefPubMedPubMedCentral

Vinogradova, Y., Coupland, C., Hippisley-Cox, J., Whyte, S., & Penny, C. (2010). Effects of severe mental illness on survival of people with diabetes. British Journal of Psychiatry, 197(4), 272–277. https://doi.org/10.1192/bjp.bp.109.074674.CrossRef

Wake, D. J., Broughton, P., Perera, S. M., MacIntyre, D. J., & Leese, G. P. (2016). Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study. Psychoneuroendocrinology, 66, 214–220. https://doi.org/10.1016/j.psyneuen.2016.01.022.CrossRefPubMed

Ward, M., & Druss, B. (2015). The epidemiology of diabetes in psychotic disorders. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(15)00007-3.CrossRefPubMed

Wetterling, T. (2001). Bodyweight gain with atypical antipsychotics: A comparative review. Drug Safety. https://doi.org/10.2165/00002018-200124010-00005.CrossRefPubMed

WHO (2018). Management of physical health conditions in adults with severe mental disorders WHO GUIDELINES. Who.

Title: Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel’s Mental Health Reform
Authors: Deborah Barasche-Berdah
Eliana Ein-Mor
Ronit Calderon-Margalit
Adam J Rose
Michal Krieger
Shuli Brammli-Greenberg
Arye Ben-Yehuda
Orly Manor
Arnon D. Cohen
Edna Bar-Ratson
Ronen Bareket
Eran Matz
Ora Paltiel
Publication date: 11-09-2023
Publisher: Springer US
Keywords: Diabetes
Care
Obesity
Obesity
Published in: Community Mental Health Journal / Issue 2/2024
Print ISSN: 0010-3853
Electronic ISSN: 1573-2789
DOI: https://doi.org/10.1007/s10597-023-01178-y

2024 ASCO Annual Meeting

Springer Medicine

Nationwide Evaluation of Quality of Care Indicators for Individuals with Severe Mental Illness and Diabetes Mellitus, Following Israel’s Mental Health Reform

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2024

The Role of Acceptance in Everyday Loneliness Among Adults with Serious Mental Illness

Patient and Provider Perspectives on Processes of Engagement in Outpatient Treatment for Opioid Use Disorder: A Scoping Review

Federally Qualified Health Centers Use of Telehealth to Deliver Integrated Behavioral Health Care During COVID-19

Suicidality Among Syrian Refugee Children in Jordan

“These Places are easy to get into but Impossible to get out of”: Women’s Pathways to Psychiatric Institutions and Barriers to Community Reentry in India

Addressing Socioeconomic Determinants of Youth Suicidal Ideation: Lessons from a Youth Development Approach in India